For Immediate Release
Ontario is helping Roche Canada expand its Mississauga facility by making it the home of a new Global Pharmaceutical Development site. This will create 200 new specialized research jobs in the region.
The expansion project will provide better healthcare to Ontarians by supporting research, which will lead to new medicines and clinical trials. The project will also create more opportunities for R&D partnerships with Ontario’s research and teaching hospitals, universities and other research institutions.
Ontario is providing better health care for all Ontarians. Partnering with local business is a key component of the McGuinty government’s plan to create new jobs and improve access to healthcare, giving Ontario families peace of mind.
“This investment not only creates 200 new jobs in Mississauga, but supports the healthcare of Ontario families for tomorrow. Roche has been a fixture in Mississauga since 1990 and today’s announcement ensures the continued growth of the company in Ontario.”
– Bob Delaney, MPP for Mississauga–Streetsville
“From the discovery of insulin to the development of 3D medical imaging technologies, Ontario has a proven track record in the development of new medicines and health technologies. We’re proud to support Roche’s latest investment, helping to bring a global pharmaceutical development mandate to Mississauga and creating new jobs for Ontario families.”
– Sandra Pupatello, Minister of Economic Development and Trade
“Bringing a Global Pharmaceutical Development site to Roche Canada is a testament to our skilled and talented workforce and offers tremendous opportunities to solidify Ontario’s reputation as a global research hub.”
– Ronnie Miller, President and CEO, Hoffmann-La Roche Ltd. (Roche Canada)
For more information:
Disponible en français